Galderma Group AG

GALD

Company Profile

  • Business description

    Galderma was formed in 1981 as a joint venture between Nestle and L’Oreal. It subsequently became a subsidiary of Nestle, called Nestle Skin Health, before being carved out and launched as a stand-alone company in 2019, acquired by a consortium led by Sweden-based EQT fund. The company went public in March 2024 and is listed on the SIX Swiss exchange. Galderma’s science-based portfolio spans multiple dermatology categories, including injectable aesthetics, dermatological skincare, and therapeutic dermatology. It derives around 40% of net sales from the US and employs around 7,00 people.

  • Contact

    Zahlerweg 10
    Zug6300
    CHE

    T: +41 584558592

    https://www.galderma.com

  • Sector

    Healthcare

    Stock type

    Defensive

  • Industry

    Drug Manufacturers - Specialty & Generic

    Fiscal Year End

    31 December 2026

    Employees

Stocks News & Analysis

stocks

Bluescope offer knocked back by board

Our view on the potential for additional offers.
stocks

AI stocks winners, laggards and losers for 2025

AI stocks flew high in 2025 despite year-end volatility. Palantir and Lam look overvalued, but opportunities remain.
stocks

12 picks for an income portfolio - Q4 2025 update

Eighteen months in and passive income growth has exceeded my target.

Morningstar Investment Ideas

Markets

Index
Last price
Change
% Change
All Ordinaries9,092.7025.500.28%
CAC 408,370.15136.231.65%
DAX 4025,368.99107.350.42%
Dow JONES (US)49,504.07237.960.48%
FTSE 10010,132.417.810.08%
HKSE26,608.48376.691.44%
NASDAQ23,671.35191.330.81%
Nikkei 22551,939.89822.631.61%
NZX 50 Index13,683.2912.96-0.09%
S&P 5006,966.280.000.00%
S&P/ASX 2008,759.4025.800.30%
SSE Composite Index4,165.2944.861.09%

Market Movers